Eupraxia Pharmaceuticals Inc (EPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 18,103 | 15,957 | 16,163 | 6,883 | 8,264 |
| Operating Income | -18,103 | -15,957 | -16,163 | -6,883 | -8,264 |
| Other Income | 3,640 | 3,316 | -547 | 513 | -478 |
| Pre-tax Income | -14,463 | -12,641 | -16,710 | -6,370 | -8,742 |
| Income Tax | 30 | 14 | 11 | -1 | 6 |
| Net Income Continuous | -14,493 | -12,655 | -16,721 | -6,369 | -8,748 |
| Minority Interests | -7 | -1 | -10 | -8 | -7 |
| Net Income | $-14,487 | $-12,653 | $-16,711 | $-6,361 | $-8,741 |
| EPS Basic Total Ops | -0.23 | -0.23 | -0.37 | -0.19 | -0.26 |
| EPS Basic Continuous Ops | -0.22 | -0.22 | -0.36 | -0.17 | -0.24 |
| EPS Diluted Total Ops | -0.23 | -0.23 | -0.37 | -0.19 | -0.26 |
| EPS Diluted Continuous Ops | -0.22 | -0.22 | -0.36 | -0.17 | -0.24 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.23 | -0.37 | -0.19 | -0.26 |
| EBITDA(a) | $-17,968 | $-15,867 | $-16,090 | $-6,820 | $-8,209 |